Issue 4, 2025

Site-specific π-clamp-mediated radiosynthesis of 68Ga and 18F PET radiopharmaceuticals

Abstract

The π-clamp-mediated conjugation method, which enables site-specific modification of cysteine residues, is a promising strategy for developing well-defined radiolabelled biomolecules for positron emission tomography (PET) imaging. We have applied this method to site-specifically attach the macrocyclic chelators “NODA” and “NODAGA” to the somatostatin receptor 2-targeted peptide, octreotate. The resulting novel NODA-octreotate and NODAGA-octreotate compounds can be radiolabelled with either [18F]AlF or [68Ga]Ga3+ respectively. In vivo PET imaging shows that the [68Ga]Ga3+-labelled derivative exhibits high stability and favourable pharmacokinetic properties.

Graphical abstract: Site-specific π-clamp-mediated radiosynthesis of 68Ga and 18F PET radiopharmaceuticals

Supplementary files

Article information

Article type
Communication
Submitted
07 Oct 2024
Accepted
04 Dec 2024
First published
09 Dec 2024
This article is Open Access
Creative Commons BY license

Chem. Commun., 2025,61, 732-735

Site-specific π-clamp-mediated radiosynthesis of 68Ga and 18F PET radiopharmaceuticals

T. T. C. Yue, J. H. Teh, E. Aboagye, M. T. Ma, T. T. Pham and N. J. Long, Chem. Commun., 2025, 61, 732 DOI: 10.1039/D4CC05223D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements